Boston, MA -- (SBWIRE) -- 10/23/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: FIRST TITAN CORP(OTCBB:FTTN), Freeport-McMoRan Copper & Gold Inc.(NYSE:FCX), Hecla Mining Company(NYSE:HL), Pain Therapeutics, Inc.(NASDAQ:PTIE)
FIRST TITAN CORP(OTCBB:FTTN) opened its shares at the price of $1.80 for the day. Its closing price was $1.84 after gaining +13.58% for the day. The company traded with the total volume of 573,605.00 shares, while its average trading volume remained 102,676.00 shares. The beta of FTTN stands at -3.02. First Titan Corp., through its subsidiary, First Titan Energy, LLC, engages in the exploration and development of oil and natural gas resources worldwide.
For How Long FTTN will Fight for Profitability? Read This Trend Analysis report
Freeport-McMoRan Copper & Gold Inc.(NYSE:FCX) percentage change surged +3.77% to close at $36.36 with the total traded volume of 28.64 million shares, and average volume of 12.38 million. The 52 week range of the stock remained $26.37 - $41.20, while its day lowest price was $36.00 and it hit its day highest price at $36.78. Freeport-McMoRan Copper & Gold Inc. engages in the exploration of mineral resource properties.
For How Long FCX’s Gloss will Attract Investors ? Find out via this report
Hecla Mining Company(NYSE:HL) started its trading session with the price of $3.34 and closed at $3.44 by scoring +4.88%. HL’s stocks traded with total volume of 7.67 million shares, while the average trading volume remained 5.58 million shares. The beta of HL stands at 2.21. Day range of the stock was $3.32 -$3.46. Hecla Mining Company, together with its subsidiaries, discovers, acquires, develops, produces, and markets precious and base metals worldwide.
Will HL Continue To Move Higher? Find Out Here
Pain Therapeutics, Inc.(NASDAQ:PTIE) ended its day with the gain of +16.00% and closed at the price of $3.77 after opening at $4.24. Stock traded during its last trading session with the total volume of 3.15 million shares, as compared to its average volume of 202,237.00 shares. Pain Therapeutics, Inc., a biopharmaceutical company, develops novel drugs. Its lead drug candidate is REMOXY (oxycodone) Extended-Release Capsules CII, an investigational drug with a controlled release formulation of oxycodone for patients with moderate-to-severe chronic pain.
Why Should Investors Buy PTIE After The Recent Gain? Just Go Here and Find Out
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/ and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)